Neogen Corporation (NEOG)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $2.45B
Last updated: Nov 17, 2026 at 11:06 AM ET
Neogen Corporation (NEOG) Earnings: Report Dates and Results
Neogen (NEOG) is expected to report earnings on Jan 6, 2027. In the quarter ended Aug 31, 2026, Neogen reported EPS of $0.07, above the $0.04 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NEOG has an expected report date of Jan 6, 2027. Analysts' consensus for the quarter ending Nov 30, 2026 is 40.0% below the $0.10 reported for the quarter ended Nov 30, 2025.
NEOG Earnings Call
The latest NEOG earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, NEOG beat 15, missed 14 and matched 11. Revenue for the quarter ended Aug 31, 2026 was $222.80M, up 6.5% from $209.20M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | $0.07 | $0.04 | N/A | +75.00% | Beat | +75.0% | 3 | 0 up, 1 down | Oct 6, 2026 | $222.80M |
| May 31, 2026 | $0.08 | $0.03 | N/A | +166.67% | Beat | +60.0% | 3 | 1 up, 0 down | Jul 30, 2026 | $225.32M |
| Feb 28, 2026 | $0.09 | $0.05 | $0.04 - $0.07 | +80.00% | Beat | -10.0% | 3 | 0 up, 2 down | Apr 9, 2026 | $211.20M |
| Nov 30, 2025 | $0.10 | $0.07 | $0.06 - $0.07 | +42.86% | Beat | -9.1% | 3 | 0 up, 1 down | Jan 8, 2026 | $224.69M |
| Aug 31, 2025 | $0.04 | $0.04 | $0.03 - $0.05 | 0.00% | In line | -42.9% | 3 | 0 up, 0 down | Oct 9, 2025 | $209.20M |
| May 31, 2025 | $0.05 | -$0.03 | N/A | +266.67% | Beat | -50.0% | 2 | 0 up, 1 down | Jul 29, 2025 | $225.48M |
| Feb 28, 2025 | $0.10 | $0.12 | $0.11 - $0.12 | -16.67% | Miss | -16.7% | 2 | 0 up, 1 down | Apr 9, 2025 | $221.00M |
| Nov 30, 2024 | $0.11 | $0.11 | $0.10 - $0.11 | 0.00% | In line | 0.0% | 2 | 0 up, 1 down | Jan 10, 2025 | $231.26M |
| Aug 31, 2024 | $0.07 | $0.09 | $0.08 - $0.09 | -22.22% | Miss | -36.4% | 2 | 0 up, 0 down | Oct 10, 2024 | $216.96M |
| May 31, 2024 | $0.10 | $0.12 | $0.11 - $0.12 | -16.67% | Miss | -28.6% | 2 | 0 up, 0 down | Jul 30, 2024 | $236.79M |
| Feb 29, 2024 | $0.12 | $0.14 | $0.14 - $0.14 | -14.29% | Miss | 0.0% | 1 | 0 up, 0 down | Apr 9, 2024 | $228.81M |
| Nov 30, 2023 | $0.11 | $0.14 | $0.14 - $0.14 | -21.43% | Miss | -26.7% | 1 | 0 up, 0 down | Jan 9, 2024 | $229.63M |
| Aug 31, 2023 | $0.11 | $0.13 | $0.11 - $0.14 | -15.38% | Miss | -26.7% | 2 | 0 up, 0 down | Oct 10, 2023 | $216.96M |
| May 31, 2023 | $0.14 | -$0.04 | -$0.07 - $0.00 | +450.00% | Beat | 0.0% | 2 | 0 up, 0 down | Jul 27, 2023 | $241.81M |
| Feb 28, 2023 | $0.12 | $0.15 | N/A | -20.00% | Miss | -7.7% | 2 | 0 up, 0 down | Mar 30, 2023 | $218.25M |
| Nov 30, 2022 | $0.15 | $0.14 | N/A | +7.14% | Beat | +50.0% | 1 | 0 up, 0 down | Jan 5, 2023 | $230.03M |
| Aug 31, 2022 | $0.15 | $0.15 | N/A | 0.00% | In line | -6.3% | 1 | 0 up, 0 down | Sep 27, 2022 | $132.35M |
| May 31, 2022 | $0.14 | $0.12 | $0.08 - $0.15 | +16.67% | Beat | -6.7% | 2 | 0 up, 0 down | Jul 26, 2022 | $140.09M |
| Feb 28, 2022 | $0.13 | $0.15 | $0.15 - $0.15 | -13.33% | Miss | 0.0% | 1 | 0 up, 0 down | Mar 24, 2022 | $128.24M |
| Nov 30, 2021 | $0.10 | $0.17 | $0.17 - $0.17 | -41.18% | Miss | -33.3% | 1 | 0 up, 0 down | Dec 21, 2021 | $130.52M |
| Aug 31, 2021 | $0.16 | $0.16 | $0.15 - $0.17 | 0.00% | In line | +6.7% | 3 | N/A | Sep 21, 2021 | $128.31M |
| May 31, 2021 | $0.15 | $0.17 | $0.16 - $0.17 | -11.76% | Miss | -6.3% | 3 | N/A | Jul 20, 2021 | $127.42M |
| Feb 28, 2021 | $0.13 | $0.13 | $0.12 - $0.14 | 0.00% | In line | +8.3% | 3 | N/A | Mar 23, 2021 | $116.71M |
| Nov 30, 2020 | $0.15 | $0.16 | $0.15 - $0.16 | -6.25% | Miss | -6.3% | 3 | N/A | Dec 22, 2020 | $115.00M |
| Aug 31, 2020 | $0.15 | $0.14 | $0.14 - $0.15 | +7.14% | Beat | +7.1% | 4 | N/A | Sep 22, 2020 | $109.33M |
| May 31, 2020 | $0.16 | $0.15 | $0.13 - $0.17 | +6.67% | Beat | +6.7% | 4 | N/A | Jul 21, 2020 | $109.07M |
| Feb 29, 2020 | $0.12 | $0.14 | $0.13 - $0.15 | -14.29% | Miss | -7.7% | 5 | N/A | Mar 24, 2020 | $99.87M |
| Nov 30, 2019 | $0.16 | $0.16 | $0.16 - $0.17 | 0.00% | In line | 0.0% | 5 | N/A | Dec 23, 2019 | $107.80M |
| Aug 31, 2019 | $0.14 | $0.15 | $0.15 - $0.16 | -6.67% | Miss | 0.0% | 6 | N/A | Sep 24, 2019 | $101.42M |
| May 31, 2019 | $0.15 | $0.15 | $0.13 - $0.16 | 0.00% | In line | -11.8% | 6 | N/A | Jul 23, 2019 | $109.76M |
| Feb 28, 2019 | $0.13 | $0.14 | $0.13 - $0.14 | -7.14% | Miss | 0.0% | 6 | N/A | Mar 26, 2019 | $97.70M |
| Nov 30, 2018 | $0.16 | $0.15 | $0.15 - $0.16 | +6.67% | Beat | +23.1% | 7 | N/A | Dec 20, 2018 | $107.10M |
| Aug 31, 2018 | $0.14 | $0.14 | $0.14 - $0.15 | 0.00% | In line | +16.7% | 7 | N/A | Sep 25, 2018 | $99.63M |
| May 31, 2018 | $0.17 | $0.15 | $0.14 - $0.17 | +13.33% | Beat | +41.7% | 8 | N/A | Jul 17, 2018 | $108.12M |
| Feb 28, 2018 | $0.13 | $0.11 | $0.10 - $0.13 | +18.18% | Beat | +30.0% | 8 | N/A | Mar 22, 2018 | $94.90M |
| Nov 30, 2017 | $0.13 | $0.13 | $0.12 - $0.14 | 0.00% | In line | +18.2% | 8 | N/A | Jan 3, 2018 | $100.70M |
| Aug 31, 2017 | $0.12 | $0.11 | N/A | +9.09% | Beat | +20.0% | 7 | N/A | Sep 19, 2017 | $94.21M |
| May 31, 2017 | $0.12 | $0.12 | N/A | 0.00% | In line | +20.0% | 6 | N/A | Jul 18, 2017 | $95.53M |
| Feb 28, 2017 | $0.10 | $0.10 | N/A | 0.00% | In line | +25.0% | N/A | N/A | Mar 21, 2017 | $88.39M |
| Nov 30, 2016 | $0.11 | $0.10 | N/A | +10.00% | Beat | +22.2% | N/A | N/A | Dec 21, 2016 | $90.72M |
Annual EPS
EPS for the fiscal year ended May 31, 2026 was $0.31, within 4 cents of the year before. It was $0.43 for the year ended May 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| May 31, 2026 | $0.31 | N/A |
| May 31, 2025 | $0.33 | -25.0% |
| May 31, 2024 | $0.44 | -21.4% |
| May 31, 2023 | $0.56 | N/A |
| May 31, 2022 | $0.53 | -8.6% |
| May 31, 2021 | $0.58 | N/A |
| May 31, 2020 | $0.58 | N/A |
| May 31, 2019 | $0.58 | N/A |
| May 31, 2018 | $0.55 | +27.9% |
| May 31, 2017 | $0.43 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 9 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,221 | 9 | |
| 2026Q2 | Jun 30, 2026 | 5,944 | 8 | |
| 2026Q1 | Mar 31, 2026 | 7,557 | 9 | |
| 2025Q4 | Dec 31, 2025 | 5,411 | 7 | |
| 2025Q3 | Sep 30, 2025 | 7,934 | 8 | |
| 2025Q2 | Jun 30, 2025 | 6,853 | 8 | |
| 2025Q1 | Mar 31, 2025 | 5,082 | 7 | |
| 2024Q4 | Dec 31, 2024 | 4,640 | 6 |
2026Q3 Earnings Call
Opening remarks
Scott Gleason Head of Investor Relations Thank you for joining us this morning for the discussion of our fiscal third quarter 2026 earnings. I'll briefly cover the non-GAAP and forward-looking language before passing the call over to our CEO, Mike Nassif; and our CFO, Bryan Riggsbee. Before the market opened today, we published our third quarter results as well as a presentation with both documents available in the Investor Relations section of our website. On our call this morning, we will refer to certain non-GAAP financial measures that we believe are useful in evaluating our performance. Reconciliations of historical non-GAAP financial measures are included in our earnings release and the presentation, Slide 2 of which provides a reminder that our remarks will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements are subject to risks that could cause actual results to be materially different from those expressed in or implied by such forward-looking statements. These risks include, among others, matters that we have described in our most recent annual report on Form 10-K and in other filings we make with the SEC. We disclaim any obligation to update these forward-looking statements. I'm now pleased to turn the call over to our CEO, Mike Nassif.
Mike Nassif Chief Executive Officer (CEO) Good morning, everyone, and thank you for joining us. I'm happy to report that we delivered solid core growth in our Food Safety segment again this quarter, including continued growth in the United States. And our growth in the quarter was consistent with current market dynamics. This is an important milestone to achieve our goal of above-market growth. We improved our adjusted EBITDA margins to some of the highest levels in recent company history at 22.8% through cost discipline. This bodes well for our future as we look to accelerate top line growth in fiscal year 2027 and beyond and helps demonstrate the inherent financial leverage in the business. At the same time, we encountered several supplier challenges stemming from third-party manufacturers that unfortunately had a meaningful impact on our Animal Safety business. While many of these issues were outside of our direct control, they don't meet the standards we've established as an organization. So in response, we've implemented a more rigorous supplier qualification and review process to strengthen reliability going forward. Meeting our customer needs remains our highest priority, and we're addressing these challenges head on with urgency and discipline. As we look at our transformation journey, we continue to be focused on three major strategic initiatives to stabilize and strengthen our mission as the market leader in food safety. First, commercial prowess. We're strengthening our sales and marketing engine by deploying an enhanced go-to-market strategy.
Frequently Asked Questions About NEOG
When is Neogen's next earnings date?
Neogen's next earnings report is expected for Jan 6, 2027.
Did NEOG beat earnings estimates last quarter?
Yes. Neogen reported EPS of $0.07 for the quarter ended Aug 31, 2026, above the $0.04 estimate, a 75.00% surprise.
What EPS do analysts expect from NEOG next quarter?
The consensus EPS estimate for Neogen for the quarter ending Nov 30, 2026 is $0.06 from 3 analysts, with estimates from $0.06 to $0.07.
How often does NEOG beat earnings estimates?
Neogen beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +76.82%.
NEOG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts